Medigen Biotechnology Corp. announced the appointment of Mr. Chieh-Liang Lin, Senior Associate Vice President of Cell Therapy Department of the company, as Chief Scientific Officer. Approved by the Board of Directors on March 11, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.65 TWD | -0.90% | -4.57% | -13.73% |
1st Jan change | Capi. | |
---|---|---|
-13.73% | 167M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- 3176 Stock
- News Medigen Biotechnology Corp.
- Medigen Biotechnology Corp. Announces Appointment of Chieh-Liang Lin as Chief Scientific Officer